Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 Mar 7;20(6):829–836. doi: 10.1016/j.bbmt.2014.02.021

Table 4.

Unadjusted probability of outcomes by donor type and age group at 5-years after HCT for the most recent cohort (2002–2007)

Outcome Matched Sibling Donor Unrelated Donor
Probability (95% CI) Probability (95% CI)
Overall survival
 Children 68 (56–81) 56 (50–62)
 AYAs 48 (38–59) 42 (37–47)
 Older adults 33 (24–46) 37 (30–44)
Leukemia-free survival
 Children 61 (49–75) 52 (46–58)
 AYAs 34 (34–54) 38 (33–43)
 Older adults 31 (23–43) 34 (28–41)
Relapse
 Children 34 (21–47) 27 (22–32)
 AYAs 31 (22–41) 31 (26–35)
 Older adults 29 (19–40) 24 (18–30)
Treatment-related mortality
 Children 5 (1–13) 21 (16–26)
 AYAs 25 (17–35) 32 (27–37)
 Older adults 39 (28–50) 42 (34–49)

Abbreviations: AYAs – Adolescent and young adults; CI – confidence intervals